Skip to main content
ConductScienceScienceDex

Qing Zhang

From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.

FY2026 NIH rank #5,950
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 8950940Search this ID in NIH RePORTER
ORCID iD
https://orcid.org/0000-0002-6595-8995Verified identifier for this researcher
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2026

Linked Award Amount
$3M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#5,950
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Qing Zhang. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

NCI

National Cancer Institute

$3M

4 awards · administering

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Qing Zhang as a PI. Multi-PI records show the full award amount for context.

  • 4R01CA294636-03R01Contact PI
    New Von Hippel Lindau (VHL) tumor suppressor signaling in renal cancer
    UT Southwestern Medical Center · Pathology (NIH department code)
    $1.6M
    award amount
  • 5R01CA294133-02R01Contact PI
    Genome-wide CRISPR screening identifies critical regulators controlling ccRCC lung metastasis
    UT Southwestern Medical Center · Pathology (NIH department code)
    $521.6K
    award amount
  • 5R01CA284591-04R01Contact PI
    Identification of DCLK2-TBK1 signaling axis as a potential therapeutic target in kidney cancer
    UT Southwestern Medical Center · Pathology (NIH department code)
    $469.9K
    award amount
  • 5R01CA274924-04R01Contact PI
    A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
    UT Southwestern Medical Center · Pathology (NIH department code)
    $427.7K
    award amount

Award organization

Organizations that administered FY2026 awards listing Qing Zhang as a PI.

FY2026 award administered by UT Southwestern Medical Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    UT Southwestern Medical Center
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #6620
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2026
    $5M Cumulative Funding

Explore further

Find collaborators for Qing Zhang

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →